OKYO Pharma Limited
OKYO · NASDAQ
3/31/2025 | 10/1/2024 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | – | $0 |
| Gross Profit | -$0 | -$0 | – | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $2 | – | $0 |
| G&A Expenses | $0 | $0 | – | $0 |
| SG&A Expenses | $4 | $1 | – | $0 |
| Sales & Mktg Exp. | $0 | $0 | – | $0 |
| Other Operating Expenses | $3 | -$3 | – | $0 |
| Operating Expenses | $7 | $0 | – | $0 |
| Operating Income | -$4 | -$3 | – | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$1 | – | -$0 |
| Pre-Tax Income | -$4 | -$4 | – | -$0 |
| Tax Expense | -$2 | -$1 | – | $0 |
| Net Income | -$2 | -$3 | – | -$0 |
| % Margin | – | – | – | – |
| EPS | -0.04 | -0.08 | – | -0.24 |
| % Growth | 49.6% | – | – | – |
| EPS Diluted | -0.04 | -0.08 | – | -0.24 |
| Weighted Avg Shares Out | 39 | 34 | – | 0 |
| Weighted Avg Shares Out Dil | 39 | 34 | – | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | – | $0 |
| Interest Expense | $0 | $1 | – | $0 |
| Depreciation & Amortization | $0 | $0 | – | $0 |
| EBITDA | -$7 | -$0 | – | -$0 |
| % Margin | – | – | – | – |